Diabetes drug shows promise for quitting smoking without weight gain
NCT ID NCT05610800
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether exenatide, a drug used for diabetes, can help people quit smoking and prevent the weight gain that often happens after quitting. 140 adults who smoked at least 5 cigarettes daily and wanted to quit took part. They received either exenatide or a placebo along with a nicotine patch. The main goals were to see if exenatide improved quit rates and reduced weight gain at 12 weeks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMOKING CESSATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Michael E. DeBakey VA Medical Center
Houston, Texas, 77030, United States
-
The University of Texas Health Science Center at Houston
Houston, Texas, 77054, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Two-Drug combo break the smoking habit?
- Personalized nicotine patch dosing may boost quit rates
- Talking it out: could a Conversation-Based approach curb smoking in future nurses?
- A stronger nicotine patch might break the dual Smoking-Vaping habit
- Free meds could boost quit rates in stroke survivors
- Can a phone app help Spanish-Speaking smokers kick the habit?